2023
DOI: 10.1007/s40615-023-01678-3
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Determinants and Implementation Strategies to Increase Long-Acting Injectable PrEP for HIV Prevention Among Latino Men Who Have Sex with Men (MSM)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 49 publications
0
1
0
Order By: Relevance
“…Factors such as human immunodeficiency virus (HIV) status, sexual orientation, and the disclosure of sexual orientation can play key roles. People living with HIV (PLWH) may face obstacles to COVID-19 vaccination due to existing health conditions and potential interactions with antiretroviral regimens [ 13 ]. Moreover, LGBTQ+ individuals might grapple with barriers to healthcare access stemming from societal prejudice, stigma, and discrimination, potentially reducing vaccination uptake [ 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…Factors such as human immunodeficiency virus (HIV) status, sexual orientation, and the disclosure of sexual orientation can play key roles. People living with HIV (PLWH) may face obstacles to COVID-19 vaccination due to existing health conditions and potential interactions with antiretroviral regimens [ 13 ]. Moreover, LGBTQ+ individuals might grapple with barriers to healthcare access stemming from societal prejudice, stigma, and discrimination, potentially reducing vaccination uptake [ 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…Potential facilitators for PrEP accessibility offered by LA-PrEP documented in recent literature include periodic (instead of daily) administration which may reduce logistical barriers and social stigma [23]. However, since FDA approval of LA-PrEP, access has been hampered by challenges in the logistics of service provision and user insurance coverage, [24][25][26] as well as low awareness and low trust in LA-PrEP [27]. While estimates are not widely available, ViiV Healthcare reported that 11,000 people were taking LA-PrEP in the U.S. as of 2023 [28].…”
Section: Introductionmentioning
confidence: 99%